NLT Spine, which already markets the Prow Fusion intervertebral body fusion device and the eSPINTM discectomy tool in the USA, has announced it has opened a subsidiary in the USA to support the commercialisation of its advanced technology platform.
According to a company press release, NLT Spine’s “non-linear” technology platform enables implantation of large spinal implants and instruments through small incisions for the treatment of degenerative conditions of the spine. It added that with the “non-linear” technology platform, implant and instrument size is not limited by the incision size. It involves segmented devices that are inserted in a straight configuration (“linear”) into the spine by the means of a conduit and are then transformed into different (“non-linear”) shapes inside the body. The conduit provides for a pathway for introduction of instruments and implants, protecting soft tissues and nerves, allowing for predictable positioning and an accurate inflexion point within the patient, and affording a more reproducible procedure. These functional characteristics can shorten the learning curve for surgeons and may help to reduce user errors associated with spine surgery. The platform is applicable to a wide variety of surgical spinal procedures representing segments that cover over 95% of the spinal implant marketplace in the USA.
Didier Toubia, NLT Spine chief executive officer, commented, “Our vision is ultimately to revolutionise the spine market and create a shift towards minimally invasive spinal surgery, similar to the way the catheter has revolutionised cardiovascular procedures. We are very pleased with the positive results from recent clinical experience and we look forward to bringing additional benefits to surgeons and hospitals in the USA.”
